Antibiotics Definitions – Flashcards
Unlock all answers in this set
Unlock answers| Types of Cell Wall Synthesis Inhibitors | 
-Lactams - Penicillin - Cephalosporin - Carbapenem - ?-Lactamase Inhibitors Vancomycin Bacitracin Cycloserine Isonziad Ethionamide Ethambutol  | 
?-Lactams MOA  | 
Interfere w/ Cell Wall Synthesis by inhibiting Penicillin Binding Proteins: Transpeptidase, Transglycosylase and Carboxypeptidase. Peptidoglycan Monomers will build up and trigger Autolytic Enzymes to kill the bacteria 
 
 EXCEPT: B-Lactamase Inhibitors  | 
| Naturally Occuring Penicillins | 
-Lactam + Thiazolidine Bacteriocidal 
 Active against: Gram(+) Cocci and Bacilli Gram(-) Cocci and Spirochetes Inactive against: Gram(-) Rods 
 
 Penicillin G = Acid Labile, Narrow Spectrum Penicillin V = Acid Stable, Narrow Spectrum  | 
Semi-Synthetic Penicillins 
  | 
-Lactam + Thiazolidine Bacteriocidal 
 Methicillin Ampicillin Nafcillin Amoxicillin Oxacillin 
 Similar to Natural Penicillin except it has better activity against Gram(-) Rods Resistant to ?-Lactamase Increased Stability in Stomach Acid  | 
| Cephalosporin | 
-Lactam + Dihydrothiazine Bacteriocidal 
 1st Gen: Cefazolin= Gram(+), Narrow Spectrum 2nd Gen: Cefuoxime= Expanded Spectrum w/ Gram(-) 3rd Gen: Cefriaxone= Broader Spectrum w/ more Gram(-) 4th Gen: Piperocillin= Extended Spectrum against Pseudomonas Aeroginosa  | 
| Carbapenems | 
Pharmacology: Bacteriocidal Broadest Spectrum in comparison to other ?-Lactams 
 Active against: Gram(-), Gram(+), Strict Anaerobes and most ?-Lactamases 
 Resistance: occurs by enzymatic inactivation by Carbapenemase Resitant Gram(-) rods are increasing  | 
| ?–Lactamase Inhibitors | 
MOA: Bind strongly to ?-Lactamase to protect ?-Lactams 
 Has very little antibacterial properties but it is used in combo w/ other ?-Lactams to protect it from degradation 
 Augmentin= Clavulenic Acid+Amoxycillin Unasym= Sulbactam+Ampicillin Zosyn= Tazobactam+Piperacillin  | 
?-Lactam Drug Resistance Mechanisms  | 
Intrinsic Resistance = Bacteria lacking a cell wall (Chlamydia, Ureaplasma, Mycoplasma, Anaplasma) 
 Mutation of Porins = decreased permeability against Gram(-) 
 Inactivating Enzymes on Plasmids = inactivates components of the drug (?-Lactamase) 
 Mutation of PBPs = MRSA  | 
Vancomyocin 
  | 
MOA: Inhibits Peptidoglycan cross-linking by binding to the terminal D-Alanine 
 Pharmacology: Bacteriocidal, Narrow Spectrum 
 Active against: Gram(+) 
 Resistance: VanA and VanB replace the terminal D-Alanine with Lactic Acid via MDR on Plasmids or Transposons 
  | 
| Bacitracin | 
MOA: Binds to Bacteroprenol and inhibits transfer of Peptidoglycan monomers 
 Pharmacology: Bacteriocidal, Narrow Spectrum, Topical 
 Active Against: Gram(+) 
 Resitance: occurs by decreasing penetrance of the drug  | 
| Cycloserine | 
MOA: Analog to D-Alanine leading inhibition of cross-linking 
 Active against: Mycobacterial Infections (Acid Fast)  | 
Isonziad (INH)  | 
MOA: Inhibits Mycolic Acid 
 Active against: Mycobacterial Infections (Acid Fast)  | 
| Ethionamide | 
MOA: Inhibits Mycolic Acid (derivative of INH) 
 Active against: Mycobacterial Infections (Acid Fast)  | 
| Ethambutol | 
MOA: Inhibits Arabagalactan synthesis which is part of the cell wall in Acid Fast bacteria 
 Active against: Mycobacterial Infections (Acid Fast)  | 
Cell Membrane Dysfunction Polymyxin B and Polymyxin E (Colistin)  | 
MOA: Cationic Detergent that disrupts the cell membrane 
 Pharmacology: Bacteriocidal, Narrow Spectrum 
 Active against: Gram(-) 
  | 
| Types of Protein Synthesis Inhibitors | 
30S: Aminoglycosides and Tetracyclines 
 50S: Macrolides, Chloramphenicol, Oxazolidinone, Streptogramin and Lincosamides  | 
Aminoglycosides (30S)  | 
MOA: Inhibits the initiation complex at 30S resulting in misreading mRNA. Its uptake depends on oxygen 
 Pharmacology: Bacteriocidal, Narrow Spectrum, Poor GI absorption. Neurotoxic to CN 8 
 Active against: Aerobic, Gram (-) Inactive against: Anaerobic, Gram (+) 
 Natural Derivatives: Tobramyocin, Neomyocin, Kanamyocin, Gentamyocin, Amikacin and Streptomycin (for Mycobacterium) 
 Synthetic Derivatives: Netilmycin and Amikacin 
 Resistance: Enzymatic Modification Transport Interference Mutation of binding sites Accelerated Export of Drug  | 
Tetracycline (30S)  | 
MOA: Binds to 30S to prevent binding of tRNA to mRNA 
 Pharmacology: Bacteriostatic, Broad Spectrum (w/ Chlamydia, Mycoplasma, Rickettsia) 
 Derivatives: Minocycline, Doxycyclin, Tetracycline 
 Side Effects: Photosensitivity, Calcium and Iron Chelator, Discoloration of Teeth 
 Resistance: Decreased Permeability, Active Efflux, Acetylation and Altered Binding Sites  | 
Macrolides (50S)  | 
MOA: Binds to 50S and prevents tRNA release AFTER peptide bond formation 
 Pharmacology: Bacteriostatic, Used when theres Penicillin Allergy, Broad Spectrum (w/ Gram(+), Gram(-), Chlamydia and Mycoplasma) 
 Derivatives: Azithromycin, Erythromycin and Clarithromycin 
 Resistance: Alteration of 50S and Enzymatic Modification 
  | 
Chloramphenicol (50S)  | 
MOA: Binds to 50S and inhibits the elongation phase by inhibiting Peptidyl Transferase (mitochondrial) 
 Pharmacology: Bacteriostatic, Broad Spectrum including Anaerobes  | 
Lincosamides (50S)  | 
MOA: Prevents peptide bond formation 
 Pharmacology: Bacteriostatic 
 Active against: Gram(+) and Anaerobes Inactive against: Gram(-) 
 Derivatives: Clindamycin and Lincomycin 
 Resistance: Methylation of 23S rRNA  | 
Streptogramins (50S)  | 
Derivative and MOA: Quinupristin - Prematurely releases Peptides Dalfopristin - Binds to 50S and prevents Elongation 
 Pharmacology: Bacteriocidal, Good for Vanco resistance with Staph and Enterococcus 
 Active against: Gram(+)  | 
Oxazolidinones/Linezolid (50S)  | 
MOA: Binds to 50S and interferes with the formation of an Initiation Complex 
 Pharmacology: Bacteriostatic, Gram(+), Reserved for VREF and MRSA  | 
| Types of Folic Acid Synthesis Inhibitors | 
Sulfanomides and Trimethoprim Para-aminosalicyclic Acid and Dapsone 
  | 
| Sulfonamides and Trimethoprim | 
MOA: Sulfonamides - Inhibits Dihydropteroate Synthase Trimethoprim - Inhibits DHF Reductase These enzymes are utilized in DNA synthesis in bacteria 
 Pharmacology: Bacteriostatic, Broad Spectrum, Usually used together 
 Active against: UTIs, GIT Infections and Respiratory Infections 
 Resistance: Overproduction of PABA or DHF, Folic Acid Dependency  | 
| Para-aminosalicyclic Acid and Dapsone | 
SIMILAR TO SULFONAMIDES AND TRIMETHOPRIM EXCEPT: 
  | 
| Types of Nucleic Acid Synthesis Inhibitors | 
Metronidazole/Flagyl Quinolones/Fluroquinolones Rifamycin  | 
| Metronidazole (Flagyl) | 
MOA: Reduced to its active form in vivo and disrupts DNA under Anaerobic conditions 
 Pharmacology: Bacteriocidal, Narrow Spectrum, active form of the drug disrupts DNA under anaerobic conditions 
 Active against: Anaerobic Bacteria, Anti-Protozoa  | 
| Quinolones/Fluoroquinolones | 
MOA: Inhibits DNA Topoisomeriase II/Gyrase and DNA Topoisomerase IV which is needed for DNA Replication, Recombination and Repair 
 Pharmacology: Bacteriocidal, Broad Spectrum, Affects bone and cartilage 
 Derivatives: Ciprofloxacin, Ofloxacin and Norfloxacin  | 
| Rifamycin | 
MOA: Inhibits DNA-dependent RNA Polymerase needed for Transcription 
 Pharmacology: Bacteriocidal, Broad Spectrum 
 Active against: Mycobacterium Tub. Gram(+) Inactive Against: Gram(-)  |